Published : Jul-2018
No. of Pages : 405
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 17
2 Introduction 18
2.1 Colorectal Cancer Diagnostic Tests Overview 18
3 Products under Development 19
3.1 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 19
3.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 20
3.3 Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 21
3.4 Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 22
3.5 Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 23
4 Colorectal Cancer Diagnostic Tests - Pipeline Products under Development by Companies 24
4.1 Colorectal Cancer Companies - Pipeline Products by Stage of Development 24
4.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 29
5 Colorectal Cancer Diagnostic Tests Companies and Product Overview 33
5.1 2cureX AB Company Overview 33
5.2 Abcodia Ltd Company Overview 36
5.3 Advanced Marker Discovery SL Company Overview 37
5.4 Advpharma Inc Company Overview 38
5.5 Almac Diagnostics Ltd Company Overview 39
5.6 Ambergen Inc Company Overview 40
5.7 ANGLE plc Company Overview 41
5.8 Applied Proteomics Inc Company Overview 42
5.9 Arizona State University Company Overview 43
5.10 ArtemixRx Company Overview 44
5.11 Avant Diagnostics, Inc. Company Overview 45
5.12 Bio Mark Ltd Company Overview 46
5.13 Biodesix Inc Company Overview 47
5.14 BioMarCare Technologies Ltd Company Overview 48
5.15 BioMark Diagnostics Inc. Company Overview 49
5.16 BioMarker Strategies LLC Company Overview 50
5.17 bioMerieux SA Company Overview 51
5.18 Biomoda Inc Company Overview 52
5.19 Bioprognos SL Company Overview 53
5.20 BioSystems International Company Overview 54
5.21 BioTime Inc Company Overview 55
5.22 Biotron Ltd Company Overview 56
5.23 Castle Biosciences Inc Company Overview 57
5.24 Catholic University of Leuven Company Overview 58
5.25 Celcuity LLC Company Overview 59
5.26 CellMax Life Inc Company Overview 60
5.27 Cellmid Ltd Company Overview 61
5.28 Ceres Nanosciences Inc Company Overview 63
5.29 Cernostics Inc Company Overview 64
5.30 ChemImage Corp Company Overview 65
5.31 China Sky One Medical Inc Company Overview 66
5.32 Columbia University Company Overview 67
5.33 CS-Keys, Inc. (Inactive) Company Overview 68
5.34 Di.V.A.L Toscana srl Company Overview 69
5.35 DiagnoCure Inc. (Inactive) Company Overview 70
5.36 Diaxonhit SA Company Overview 72
5.37 Diazyme Laboratories Inc Company Overview 73
5.38 DNAlytics Company Overview 74
5.39 EDP Biotech Corporation Company Overview 77
5.40 Epigenomics AG Company Overview 78
5.41 Eventus Diagnostics Inc (Inactive) Company Overview 80
5.42 Exact Sciences Corp Company Overview 81
5.43 Exiqon A/S Company Overview 82
5.44 Exosomics Siena SpA Company Overview 83
5.45 Fina Biotech SL Company Overview 84
5.46 Fox Chase Cancer Center Company Overview 85
5.47 GenomicTree Inc Company Overview 86
5.48 German Cancer Research Center Company Overview 88
5.49 Ghent University Company Overview 90
5.50 GlycoZym Company Overview 91
5.51 Health Discovery Corp Company Overview 92
5.52 Hitachi Ltd Company Overview 93
5.53 Human Metabolome Technologies Inc Company Overview 94
5.54 Ikonisys Inc Company Overview 95
5.55 Institute of Molecular and Translational Medicine Company Overview 96
5.56 InterGenetics Inc Company Overview 97
5.57 IV Diagnostics Inc Company Overview 98
5.58 Johns Hopkins University Company Overview 99
5.59 King Abdullah University of Science and Technology Company Overview 101
5.60 Kyo Diagnostics KK Company Overview 102
5.61 Lab21 Ltd Company Overview 103
5.62 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview 104
5.63 Leitat Technological Center Company Overview 105
5.64 Lightsphere Diagnostics Company Overview 107
5.65 MabCure Inc. Company Overview 108
5.66 Master Diagnostica Sociedad Limitada Company Overview 109
5.67 Matrix-Bio, Inc. Company Overview 110
5.68 Max Delbruck Center for Molecular Medicine Company Overview 113
5.69 Mayo Clinic Company Overview 114
5.70 MDNA Life Sciences Inc Company Overview 115
5.71 MDxHealth SA Company Overview 116
5.72 Merrimack Pharmaceuticals Inc Company Overview 118
5.73 Metabiomics Corporation Company Overview 119
5.74 Metabolon Inc Company Overview 121
5.75 MetaStat Inc Company Overview 122
5.76 Milagen Inc Company Overview 123
5.77 Myriad Genetics Inc Company Overview 124
5.78 Nanocytomics LLC Company Overview 125
5.79 Natera Inc Company Overview 126
5.80 Norda ASA Company Overview 127
5.81 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 128
5.82 Nuclea Biotechnologies Inc. (Inactive) Company Overview 129
5.83 Oncimmune (USA) LLC Company Overview 130
5.84 Onconome, Inc. (Inactive) Company Overview 131
5.85 OncoStem Diagnostics Pvt. Ltd Company Overview 132
5.86 On-Q-ity, Inc. (Inactive) Company Overview 133
5.87 Origin Sciences Ltd Company Overview 134
5.88 Orion Genomics LLC Company Overview 135
5.89 OTraces Inc. Company Overview 136
5.90 Oxford Cancer Biomarkers Ltd Company Overview 137
5.91 Oxford Gene Technology Ltd Company Overview 138
5.92 PleX Diagnostics Inc (Inactive) Company Overview 139
5.93 Precision Biologics Inc Company Overview 140
5.94 Prediction Sciences LLC (Inactive) Company Overview 141
5.95 PreMD Inc (Inactive) Company Overview 142
5.96 Protagen AG Company Overview 143
5.97 Protein Alternatives SL Company Overview 144
5.98 Qiagen NV Company Overview 145
5.99 Quest Diagnostics Inc Company Overview 146
5.100 Rabin Medical Center Company Overview 147
5.101 Rhythm Biosciences Ltd Company Overview 148
5.102 RISE Life Science Corp Company Overview 149
5.103 Rna Diagnostics Inc Company Overview 150
5.104 Rosetta Genomics Ltd Company Overview 151
5.105 Scienion AG Company Overview 152
5.106 Seegene Inc Company Overview 153
5.107 Shuwen Biotech Co Ltd Company Overview 154
5.108 Sysmex Corp Company Overview 155
5.109 Tel Aviv University Company Overview 156
5.110 The Chinese University of Hong Kong Company Overview 157
5.111 The Walter and Eliza Hall Institute of Medical Research Company Overview 158
5.112 TheraDiag SA Company Overview 159
5.113 Treos Bio Inc Company Overview 161
5.114 Trinity College Dublin Company Overview 162
5.115 Universal Diagnostics SL Company Overview 163
5.116 University of Illinois at Chicago Company Overview 164
5.117 University of Lyon Company Overview 165
5.118 University of Michigan Company Overview 166
5.119 University of Notre Dame Company Overview 167
5.120 University of Pittsburgh Company Overview 168
5.121 University of Texas MD Anderson Cancer Center Company Overview 171
5.122 University of Turku Company Overview 172
5.123 University of Washington Company Overview 173
5.124 University of Wisconsin Madison Company Overview 174
5.125 US Biomarkers Inc Company Overview 175
5.126 vall d hebron institut de Recerca Company Overview 176
5.127 Vanderbilt University Company Overview 178
5.128 Viomics Inc. Company Overview 180
5.129 VolitionRX Ltd Company Overview 181
5.130 XEPTAGEN SpA Company Overview 191
6 Colorectal Cancer Diagnostic Tests - Recent Developments 192
6.1 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 192
6.2 Jun 29, 2018: GeneNews Announces Directors Election 192
6.3 Jun 21, 2018: 2cureX presents positive clinical data from its IndiTreat CRC trial at ESMO in Barcelona 193
6.4 Jun 21, 2018: Rhythm Biosciences completes cloning step of key reagent development ahead of schedule 193
6.5 Jun 20, 2018: Colorectal Cancer Is on the Rise in Young Adults; a simple blood test could improve screening compliance 194
6.6 Jun 20, 2018: Colorectal Cancer Is on the Rise in Young Adults; a simple blood test could improve screening compliance 195
6.7 Jun 19, 2018: Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer 195
6.8 Jun 19, 2018: Polymedco Announces Updated American Cancer Society Guidelines for Colorectal Cancer Screening 196
6.9 Jun 13, 2018: Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John Ryals 197
6.10 Jun 13, 2018: Vermillion Appoints Chris Goulart As Senior Vice President Of Commercial Operations 198
6.11 Jun 12, 2018: OGT expands custom NGS cancer panel content 198
6.12 Jun 07, 2018: CENTOGENE Partners with the Universities of Greifswald and Rostock to Develop Fast-Tracked Diagnostic Workflow for Personalized Immune-based Therapies for Colon and Pancreatic Tumors 199
6.13 Jun 05, 2018: AgeX Therapeutics Appoints John F. Mauldin to Board of Directors 199
6.14 Jun 01, 2018: Gopath Labs Announces North American Launch of MiR-31-3p Expression Test 200
6.15 Jun 01, 2018: Immunoscore: a test to improve the care and treatment of colon cancer 200
7 Appendix 399
7.1 Methodology 399
7.2 About GlobalData 402
7.3 Contact Us 402
7.4 Disclaimer 402
1.1 List of Tables
Table 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 22
Table 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 23
Table 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Table 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Table 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 26
Table 6: Colorectal Cancer Companies - Pipeline Products by Stage of Development 27
Table 7: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 32
Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview 36
Table 9: IndiTreat - CRC - Product Status 36
Table 10: IndiTreat - CRC - Product Description 36
Table 11: 2cureX AB - Ongoing Clinical Trials Overview 37
Table 12: IndiTreat - CRC - Clinical Evaluation of IndiTreat test for Patients with Stage IV Colorectal Cancer 38
Table 13: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 14: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status 39
Table 15: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description 39
Table 16: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 40
Table 17: ColoFast - Product Status 40
Table 18: ColoFast - Product Description 40
Table 19: Advpharma Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 20: Molecular Diagnostic Biomarker - Colorectal Cancer Diagnostic Tests - Product Status 41
Table 21: Molecular Diagnostic Biomarker - Colorectal Cancer Diagnostic Tests - Product Description 41
Table 22: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
Table 23: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Status 42
Table 24: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Description 42
Table 25: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 26: Veracode - Colorectal Cancer Diagnostic Tests - Product Status 43
Table 27: Veracode - Colorectal Cancer Diagnostic Tests - Product Description 43
Table 28: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 29: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Status 44
Table 30: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Description 44
Table 31: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 32: SimpliPro Colon-A - Product Status 45
Table 33: SimpliPro Colon-A - Product Description 45
Table 34: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 46
Table 35: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status 46
Table 36: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description 46
Table 37: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 47
Table 38: ArtemixRx Prognostic Test - Colon Cancer - Product Status 47
Table 39: ArtemixRx Prognostic Test - Colon Cancer - Product Description 47
Table 40: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
Table 41: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Status 48
Table 42: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Description 48
Table 43: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
Table 44: Diagnostic Test - Colorectal Adenoma - Product Status 49
Table 45: Diagnostic Test - Colorectal Adenoma - Product Description 49
Table 46: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 47: VeriStrat - Colorectal Cancer Diagnostic Tests - Product Status 50
Table 48: VeriStrat - Colorectal Cancer Diagnostic Tests - Product Description 50
Table 49: BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 50: mCRC-Strat - Product Status 51
Table 51: mCRC-Strat - Product Description 51
Table 52: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 53: Metabolomics-based Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status 52
Table 54: Metabolomics-based Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description 52
Table 55: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 53
Table 56: Ex Vivo Biomarker Test - Colon Cancer - Product Status 53
Table 57: Ex Vivo Biomarker Test - Colon Cancer - Product Description 53
Table 58: bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 54
Table 59: Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status 54
Table 60: Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description 54
Table 61: Biomoda Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 62: CyPath Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status 55
Table 63: CyPath Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description 55
Table 64: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview 56
Table 65: MBDAA Colorectal Cancer Test - Product Status 56
Table 66: MBDAA Colorectal Cancer Test - Product Description 56
Table 67: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 57
Table 68: Diagnostic Test - Colon Cancer - Product Status 57
Table 69: Diagnostic Test - Colon Cancer - Product Description 57
Table 70: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 71: PanC-Dx - Colon Cancer - Product Status 58
Table 72: PanC-Dx - Colon Cancer - Product Description 58
Table 73: Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
Table 74: C-Test - Colorectal Cancer Diagnostic Tests - Product Status 59
Table 75: C-Test - Colorectal Cancer Diagnostic Tests - Product Description 59
Table 76: Castle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 77: DecisionDx - Rectal Cancer - Product Status 60
Table 78: DecisionDx - Rectal Cancer - Product Description 60
Table 79: Catholic University of Leuven Pipeline Products & Ongoing Clinical Trials Overview 61
Table 80: Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Status 61
Table 81: Diagnostic Test - Colorectal Cancer Diagnostic Tests - Product Description 61
Table 82: Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview 62
Table 83: CELx Test - Colon Cancer - Product Status 62
Table 84: CELx Test - Colon Cancer - Product Description 62
Table 85: CellMax Life Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 86: CellMax Monitor - Colorectal Cancer Diagnostic Tests - Product Status 63
Table 87: CellMax Monitor - Colorectal Cancer Diagnostic Tests - Product Description 63
Table 88: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
Table 89: MK-ELISA Assay - Colorectal Cancer Diagnostic Tests - Product Status 64
Table 90: MK-ELISA Assay - Colorectal Cancer Diagnostic Tests - Product Description 64
Table 91: MK-ELISA Assay - Metastatic Colorectal Cancer Diagnostic Tests - Product Status 65
Table 92: MK-ELISA Assay - Metastatic Colorectal Cancer Diagnostic Tests - Product Description 65
Table 93: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 94: Nanotrap Colon Cancer Biomarker Test - Product Status 66
Table 95: Nanotrap Colon Cancer Biomarker Test - Product Description 66
Table 96: Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 67
Table 97: TissueCypher Colon Cancer Test - Product Status 67
Table 98: TissueCypher Colon Cancer Test - Product Description 67
Table 99: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 68
Table 100: Raman Assay - Colorectal Cancer Diagnostic Tests - Product Status 68
Table 101: Raman Assay - Colorectal Cancer Diagnostic Tests - Product Description 68
Table 102: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 103: Diagnostic Kit - Rectum Cancer - Product Status 69
Table 104: Diagnostic Kit - Rectum Cancer - Product Description 69
Table 105: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 70
Table 106: IGFBP-3 Diagnostic Test - Product Status 70
Table 107: IGFBP-3 Diagnostic Test - Product Description 70
Table 108: CS-Keys, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71
Table 109: caPCNA Test - Colorectal Cancer Diagnostic Tests - Product Status 71
1.2 List of Figures
Figure 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development 22
Figure 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory 23
Figure 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 24
Figure 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 25
Figure 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials 26
